KOZO TOMATSU

657 total citations
17 papers, 564 citations indexed

About

KOZO TOMATSU is a scholar working on Pharmacology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, KOZO TOMATSU has authored 17 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in KOZO TOMATSU's work include Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Antifungal resistance and susceptibility (4 papers). KOZO TOMATSU is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Antifungal resistance and susceptibility (4 papers). KOZO TOMATSU collaborates with scholars based in Japan, Germany and United States. KOZO TOMATSU's co-authors include TOSHIKAZU OKI, Minoru Hirano, Hideo Kamei, MASATAKA KONISHI, Takeo Miyaki, Hiroshi Kawaguchi, Koji Tomita, Kei-Ichi Numata, KYOICHIRO SAITOH and MAKI NISHIO and has published in prestigious journals such as Annals of the New York Academy of Sciences, Antimicrobial Agents and Chemotherapy and The Journal of Antibiotics.

In The Last Decade

KOZO TOMATSU

17 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
KOZO TOMATSU Japan 12 246 241 203 94 86 17 564
TAKAO NOTO United States 8 181 0.7× 242 1.0× 211 1.0× 105 1.1× 53 0.6× 12 518
Giancarlo Lancini Italy 19 280 1.1× 476 2.0× 339 1.7× 118 1.3× 103 1.2× 48 988
Patrick Laurin France 10 392 1.6× 354 1.5× 194 1.0× 80 0.9× 154 1.8× 12 719
JOSEPH O''SULLIVAN Malaysia 16 181 0.7× 336 1.4× 303 1.5× 61 0.6× 32 0.4× 40 660
F Ripamonti Italy 10 208 0.8× 289 1.2× 253 1.2× 73 0.8× 42 0.5× 18 541
S. Sugawara Japan 15 197 0.8× 237 1.0× 238 1.2× 43 0.5× 65 0.8× 64 733
Thomas F. Butler United States 11 123 0.5× 228 0.9× 150 0.7× 170 1.8× 63 0.7× 18 479
Stephen C. Wilkie United States 5 189 0.8× 262 1.1× 225 1.1× 157 1.7× 45 0.5× 6 456
F. T. COUNTER United States 13 234 1.0× 229 1.0× 178 0.9× 84 0.9× 52 0.6× 26 555
R. NAGARAJAN United States 9 238 1.0× 276 1.1× 190 0.9× 178 1.9× 37 0.4× 10 577

Countries citing papers authored by KOZO TOMATSU

Since Specialization
Citations

This map shows the geographic impact of KOZO TOMATSU's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KOZO TOMATSU with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KOZO TOMATSU more than expected).

Fields of papers citing papers by KOZO TOMATSU

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by KOZO TOMATSU. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KOZO TOMATSU. The network helps show where KOZO TOMATSU may publish in the future.

Co-authorship network of co-authors of KOZO TOMATSU

This figure shows the co-authorship network connecting the top 25 collaborators of KOZO TOMATSU. A scholar is included among the top collaborators of KOZO TOMATSU based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with KOZO TOMATSU. KOZO TOMATSU is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
OKI, TOSHIKAZU, Osamu Tenmyo, Minoru Hirano, KOZO TOMATSU, & Hideo Kamei. (1990). Pradimicins A, B and C: New antifungal antibiotics. II. In vitro and in vivo biological activities.. The Journal of Antibiotics. 43(7). 763–770. 82 indexed citations
2.
Kamachi, Hajime, MASAHISA OKA, Yukio Narita, et al.. (1990). Synthesis of a new series of cephalosporins having 3-substituted-ammonio-1-propenyl group as the C-3 side chain.. The Journal of Antibiotics. 43(5). 533–543. 10 indexed citations
3.
NISHIO, MAKI, KOZO TOMATSU, MASATAKA KONISHI, et al.. (1989). Karnamicin, a complex of new antifungal antibiotics. I. Taxonomy, fermentation, isolation and physico-chemical and biological properties.. The Journal of Antibiotics. 42(6). 852–868. 11 indexed citations
4.
OKI, TOSHIKAZU, Minoru Hirano, KOZO TOMATSU, Kei-Ichi Numata, & Hideo Kamei. (1989). Cispentacin, a new antifungal antibiotic. II. In vitro and in vivo antifungal activities.. The Journal of Antibiotics. 42(12). 1756–1762. 108 indexed citations
5.
TOMATSU, KOZO, Minoru Hirano, Hiroshi Kawaguchi, et al.. (1989). In vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232, and its prodrug esters. Antimicrobial Agents and Chemotherapy. 33(4). 489–497. 9 indexed citations
6.
TOMATSU, KOZO, et al.. (1989). Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.. PubMed. 15(1). 1–10. 11 indexed citations
7.
Kamachi, Hajime, Yukio Narita, Takaaki Okita, et al.. (1988). Synthesis and biological activity of a new cephalosporin, BMY-28232 and its prodrug-type esters for oral use.. The Journal of Antibiotics. 41(11). 1602–1616. 19 indexed citations
8.
OKI, TOSHIKAZU, MASATAKA KONISHI, KOZO TOMATSU, et al.. (1988). Pradimicin, a novel class of potent antifungal antibiotics.. The Journal of Antibiotics. 41(11). 1701–1704. 160 indexed citations
9.
Mitsuhashi, Susumu, et al.. (1988). Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.. The Journal of Antibiotics. 41(1). 86–93. 29 indexed citations
10.
SAITOH, KYOICHIRO, et al.. (1988). Novel Antifungal Antibiotic BMY‐28567. Annals of the New York Academy of Sciences. 544(1). 184–187. 17 indexed citations
11.
TOMATSU, KOZO, et al.. (1987). In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.. The Journal of Antibiotics. 40(8). 1175–1183. 11 indexed citations
12.
TOMATSU, KOZO, et al.. (1987). In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100. European Journal of Clinical Microbiology & Infectious Diseases. 6(5). 559–563. 10 indexed citations
13.
NAITÔ, TAKAYUKI, et al.. (1987). Synthesis and structure-activity relationships of a new oral cephalosporin, BMY-28100 and related compounds.. The Journal of Antibiotics. 40(7). 991–1005. 27 indexed citations
14.
TOMATSU, KOZO, et al.. (1986). Antibacterial activity of BMY-28142, a novel broad-spectrum cephalosporin.. The Journal of Antibiotics. 39(11). 1584–1591. 14 indexed citations
15.
TSUNAKAWA, MITSUAKI, Minoru Hanada, Hiroshi Tsukiura, et al.. (1985). Inosamycin, a complex of new aminoglycoside antibiotics. I. Production, isolation and properties.. The Journal of Antibiotics. 38(10). 1302–1312. 8 indexed citations
16.
KONISHI, MASATAKA, Koko Sugawara, Minoru Hanada, et al.. (1984). Empedopeptin (BMY-28117), a new depsipeptide antibiotic. I. Production, isolation and properties.. The Journal of Antibiotics. 37(9). 949–957. 26 indexed citations
17.
NAITÔ, TAKAYUKI, Susumu Nakagawa, Takaaki Okita, et al.. (1982). Synthesis and bronchodilating activity of 2,9-disubstituted adenine derivatives: BB-1502 (9-cyclohexy-2-n-propoxy-9H-adenine) and its analogs.. Chemical and Pharmaceutical Bulletin. 30(6). 2011–2019. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026